nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CYP3A4—Temozolomide—malignant glioma	0.382	1	CbGbCtD
Solifenacin—Drug interaction—Carmustine—malignant glioma	0.0124	0.0309	CcSEcCtD
Solifenacin—Dry eye—Temozolomide—malignant glioma	0.0103	0.0256	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00854	0.0213	CcSEcCtD
Solifenacin—Liver function test abnormal—Carmustine—malignant glioma	0.0077	0.0192	CcSEcCtD
Solifenacin—Dry skin—Temozolomide—malignant glioma	0.00739	0.0184	CcSEcCtD
Solifenacin—Muscular weakness—Carmustine—malignant glioma	0.00735	0.0183	CcSEcCtD
Solifenacin—Muscular weakness—Temozolomide—malignant glioma	0.00711	0.0177	CcSEcCtD
Solifenacin—Dysuria—Temozolomide—malignant glioma	0.00651	0.0162	CcSEcCtD
Solifenacin—Depression—Carmustine—malignant glioma	0.00641	0.016	CcSEcCtD
Solifenacin—Renal failure—Carmustine—malignant glioma	0.00632	0.0158	CcSEcCtD
Solifenacin—Urinary tract infection—Carmustine—malignant glioma	0.00625	0.0156	CcSEcCtD
Solifenacin—Infestation NOS—Temozolomide—malignant glioma	0.00621	0.0155	CcSEcCtD
Solifenacin—Infestation—Temozolomide—malignant glioma	0.00621	0.0155	CcSEcCtD
Solifenacin—Depression—Temozolomide—malignant glioma	0.00619	0.0154	CcSEcCtD
Solifenacin—Urinary tract infection—Temozolomide—malignant glioma	0.00604	0.0151	CcSEcCtD
Solifenacin—Hepatobiliary disease—Temozolomide—malignant glioma	0.00587	0.0146	CcSEcCtD
Solifenacin—Hallucination—Carmustine—malignant glioma	0.00574	0.0143	CcSEcCtD
Solifenacin—Oedema peripheral—Carmustine—malignant glioma	0.00568	0.0142	CcSEcCtD
Solifenacin—Connective tissue disorder—Carmustine—malignant glioma	0.00567	0.0141	CcSEcCtD
Solifenacin—Hallucination—Temozolomide—malignant glioma	0.00555	0.0138	CcSEcCtD
Solifenacin—Pharyngitis—Temozolomide—malignant glioma	0.00553	0.0138	CcSEcCtD
Solifenacin—Urinary tract disorder—Temozolomide—malignant glioma	0.00551	0.0137	CcSEcCtD
Solifenacin—Oedema peripheral—Temozolomide—malignant glioma	0.00549	0.0137	CcSEcCtD
Solifenacin—Connective tissue disorder—Temozolomide—malignant glioma	0.00548	0.0137	CcSEcCtD
Solifenacin—Urethral disorder—Temozolomide—malignant glioma	0.00546	0.0136	CcSEcCtD
Solifenacin—Eye disorder—Carmustine—malignant glioma	0.00539	0.0134	CcSEcCtD
Solifenacin—Erythema multiforme—Temozolomide—malignant glioma	0.00527	0.0131	CcSEcCtD
Solifenacin—Eye disorder—Temozolomide—malignant glioma	0.00521	0.013	CcSEcCtD
Solifenacin—Cardiac disorder—Temozolomide—malignant glioma	0.00517	0.0129	CcSEcCtD
Solifenacin—Angiopathy—Temozolomide—malignant glioma	0.00506	0.0126	CcSEcCtD
Solifenacin—Mental disorder—Carmustine—malignant glioma	0.00505	0.0126	CcSEcCtD
Solifenacin—Immune system disorder—Temozolomide—malignant glioma	0.00504	0.0126	CcSEcCtD
Solifenacin—Mediastinal disorder—Temozolomide—malignant glioma	0.00502	0.0125	CcSEcCtD
Solifenacin—Malnutrition—Carmustine—malignant glioma	0.00502	0.0125	CcSEcCtD
Solifenacin—Mental disorder—Temozolomide—malignant glioma	0.00488	0.0122	CcSEcCtD
Solifenacin—Malnutrition—Temozolomide—malignant glioma	0.00485	0.0121	CcSEcCtD
Solifenacin—Dysgeusia—Temozolomide—malignant glioma	0.00475	0.0119	CcSEcCtD
Solifenacin—Vision blurred—Carmustine—malignant glioma	0.00473	0.0118	CcSEcCtD
Solifenacin—Vision blurred—Temozolomide—malignant glioma	0.00457	0.0114	CcSEcCtD
Solifenacin—Angioedema—Temozolomide—malignant glioma	0.00443	0.0111	CcSEcCtD
Solifenacin—Hypertension—Carmustine—malignant glioma	0.00434	0.0108	CcSEcCtD
Solifenacin—Palpitations—Temozolomide—malignant glioma	0.00429	0.0107	CcSEcCtD
Solifenacin—Cough—Temozolomide—malignant glioma	0.00423	0.0106	CcSEcCtD
Solifenacin—Hypertension—Temozolomide—malignant glioma	0.00419	0.0104	CcSEcCtD
Solifenacin—Confusional state—Carmustine—malignant glioma	0.00413	0.0103	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0041	0.0102	CcSEcCtD
Solifenacin—Infection—Carmustine—malignant glioma	0.00407	0.0102	CcSEcCtD
Solifenacin—Dry mouth—Temozolomide—malignant glioma	0.00404	0.0101	CcSEcCtD
Solifenacin—Tachycardia—Carmustine—malignant glioma	0.004	0.00998	CcSEcCtD
Solifenacin—Confusional state—Temozolomide—malignant glioma	0.00399	0.00996	CcSEcCtD
Solifenacin—Anaphylactic shock—Temozolomide—malignant glioma	0.00396	0.00988	CcSEcCtD
Solifenacin—Infection—Temozolomide—malignant glioma	0.00393	0.00981	CcSEcCtD
Solifenacin—Nervous system disorder—Temozolomide—malignant glioma	0.00388	0.00969	CcSEcCtD
Solifenacin—Skin disorder—Temozolomide—malignant glioma	0.00385	0.00959	CcSEcCtD
Solifenacin—Somnolence—Carmustine—malignant glioma	0.00364	0.00909	CcSEcCtD
Solifenacin—Decreased appetite—Carmustine—malignant glioma	0.00356	0.00889	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00354	0.00882	CcSEcCtD
Solifenacin—Somnolence—Temozolomide—malignant glioma	0.00352	0.00878	CcSEcCtD
Solifenacin—Constipation—Carmustine—malignant glioma	0.0035	0.00874	CcSEcCtD
Solifenacin—Dyspepsia—Temozolomide—malignant glioma	0.00349	0.00869	CcSEcCtD
Solifenacin—Decreased appetite—Temozolomide—malignant glioma	0.00344	0.00859	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00342	0.00853	CcSEcCtD
Solifenacin—Fatigue—Temozolomide—malignant glioma	0.00341	0.00852	CcSEcCtD
Solifenacin—Constipation—Temozolomide—malignant glioma	0.00339	0.00845	CcSEcCtD
Solifenacin—Feeling abnormal—Carmustine—malignant glioma	0.00338	0.00842	CcSEcCtD
Solifenacin—Gastrointestinal pain—Carmustine—malignant glioma	0.00335	0.00836	CcSEcCtD
Solifenacin—Feeling abnormal—Temozolomide—malignant glioma	0.00326	0.00814	CcSEcCtD
Solifenacin—Abdominal pain—Carmustine—malignant glioma	0.00324	0.00808	CcSEcCtD
Solifenacin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00324	0.00808	CcSEcCtD
Solifenacin—Urticaria—Temozolomide—malignant glioma	0.00315	0.00785	CcSEcCtD
Solifenacin—Abdominal pain—Temozolomide—malignant glioma	0.00313	0.00781	CcSEcCtD
Solifenacin—Hypersensitivity—Carmustine—malignant glioma	0.00302	0.00753	CcSEcCtD
Solifenacin—Asthenia—Carmustine—malignant glioma	0.00294	0.00733	CcSEcCtD
Solifenacin—Hypersensitivity—Temozolomide—malignant glioma	0.00292	0.00728	CcSEcCtD
Solifenacin—Asthenia—Temozolomide—malignant glioma	0.00284	0.00709	CcSEcCtD
Solifenacin—Pruritus—Temozolomide—malignant glioma	0.0028	0.00699	CcSEcCtD
Solifenacin—Dizziness—Carmustine—malignant glioma	0.00271	0.00676	CcSEcCtD
Solifenacin—Dizziness—Temozolomide—malignant glioma	0.00262	0.00653	CcSEcCtD
Solifenacin—Vomiting—Carmustine—malignant glioma	0.00261	0.0065	CcSEcCtD
Solifenacin—Rash—Carmustine—malignant glioma	0.00258	0.00644	CcSEcCtD
Solifenacin—Dermatitis—Carmustine—malignant glioma	0.00258	0.00644	CcSEcCtD
Solifenacin—Headache—Carmustine—malignant glioma	0.00257	0.0064	CcSEcCtD
Solifenacin—Vomiting—Temozolomide—malignant glioma	0.00252	0.00628	CcSEcCtD
Solifenacin—Rash—Temozolomide—malignant glioma	0.0025	0.00623	CcSEcCtD
Solifenacin—Dermatitis—Temozolomide—malignant glioma	0.0025	0.00622	CcSEcCtD
Solifenacin—Headache—Temozolomide—malignant glioma	0.00248	0.00619	CcSEcCtD
Solifenacin—Nausea—Carmustine—malignant glioma	0.00243	0.00607	CcSEcCtD
Solifenacin—Nausea—Temozolomide—malignant glioma	0.00235	0.00587	CcSEcCtD
Solifenacin—CHRM5—Signaling Pathways—PIK3CG—malignant glioma	7.24e-05	0.000334	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDKN2B—malignant glioma	7.23e-05	0.000334	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDKN2B—malignant glioma	7.21e-05	0.000333	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP3—malignant glioma	7.2e-05	0.000333	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	7.18e-05	0.000332	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.16e-05	0.00033	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EGF—malignant glioma	7.15e-05	0.00033	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	7.14e-05	0.00033	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PTPN11—malignant glioma	7.11e-05	0.000328	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—BRAF—malignant glioma	7.1e-05	0.000328	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PTK2—malignant glioma	7.02e-05	0.000324	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PTK2—malignant glioma	7e-05	0.000323	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCL8—malignant glioma	6.99e-05	0.000323	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCL8—malignant glioma	6.97e-05	0.000322	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PTK2—malignant glioma	6.93e-05	0.00032	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AKT2—malignant glioma	6.91e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	6.9e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HES1—malignant glioma	6.9e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—EGFR—malignant glioma	6.88e-05	0.000318	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HES1—malignant glioma	6.88e-05	0.000318	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NCOR1—malignant glioma	6.86e-05	0.000317	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NCOR1—malignant glioma	6.84e-05	0.000316	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HES1—malignant glioma	6.81e-05	0.000314	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—BRAF—malignant glioma	6.8e-05	0.000314	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NCOR1—malignant glioma	6.77e-05	0.000313	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—RAF1—malignant glioma	6.77e-05	0.000312	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—RAF1—malignant glioma	6.75e-05	0.000311	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—IL2—malignant glioma	6.68e-05	0.000308	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—RAF1—malignant glioma	6.68e-05	0.000308	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CAV1—malignant glioma	6.67e-05	0.000308	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—IL2—malignant glioma	6.66e-05	0.000308	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PIK3CD—malignant glioma	6.64e-05	0.000307	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AKT2—malignant glioma	6.62e-05	0.000306	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	6.61e-05	0.000305	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—IL2—malignant glioma	6.6e-05	0.000305	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—EGFR—malignant glioma	6.59e-05	0.000304	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	6.59e-05	0.000304	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—PIK3CA—malignant glioma	6.58e-05	0.000304	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	6.57e-05	0.000303	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	6.55e-05	0.000302	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—IDH1—malignant glioma	6.55e-05	0.000302	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	6.52e-05	0.000301	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—KRAS—malignant glioma	6.5e-05	0.0003	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	6.49e-05	0.000299	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SPP1—malignant glioma	6.38e-05	0.000294	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CD—malignant glioma	6.36e-05	0.000294	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—FGF2—malignant glioma	6.36e-05	0.000294	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SPP1—malignant glioma	6.36e-05	0.000293	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	6.35e-05	0.000293	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SPHK1—malignant glioma	6.34e-05	0.000292	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	6.33e-05	0.000292	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—PIK3CA—malignant glioma	6.3e-05	0.000291	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SPP1—malignant glioma	6.3e-05	0.000291	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	6.27e-05	0.000289	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—KRAS—malignant glioma	6.23e-05	0.000287	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.21e-05	0.000287	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—FGF2—malignant glioma	6.09e-05	0.000281	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CG—malignant glioma	6.07e-05	0.00028	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL2—malignant glioma	6.07e-05	0.00028	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL2—malignant glioma	6.05e-05	0.000279	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TERT—malignant glioma	6.05e-05	0.000279	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TERT—malignant glioma	6.03e-05	0.000278	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL2—malignant glioma	5.99e-05	0.000277	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—PIK3CA—malignant glioma	5.97e-05	0.000276	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TERT—malignant glioma	5.97e-05	0.000276	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MDM2—malignant glioma	5.95e-05	0.000275	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—RAF1—malignant glioma	5.93e-05	0.000274	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PDGFB—malignant glioma	5.9e-05	0.000272	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PDGFB—malignant glioma	5.88e-05	0.000272	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FGFR1—malignant glioma	5.87e-05	0.000271	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ERBB2—malignant glioma	5.87e-05	0.000271	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARG—malignant glioma	5.86e-05	0.000271	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FGFR1—malignant glioma	5.85e-05	0.00027	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PDGFB—malignant glioma	5.83e-05	0.000269	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FGFR1—malignant glioma	5.8e-05	0.000268	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PIK3CB—malignant glioma	5.79e-05	0.000267	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HIF1A—malignant glioma	5.78e-05	0.000267	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HIF1A—malignant glioma	5.76e-05	0.000266	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—PIK3CA—malignant glioma	5.72e-05	0.000264	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HIF1A—malignant glioma	5.71e-05	0.000264	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MDM2—malignant glioma	5.7e-05	0.000263	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RAF1—malignant glioma	5.68e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ERBB2—malignant glioma	5.62e-05	0.000259	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CAV1—malignant glioma	5.59e-05	0.000258	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CAV1—malignant glioma	5.58e-05	0.000257	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL8—malignant glioma	5.56e-05	0.000257	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CB—malignant glioma	5.54e-05	0.000256	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KDR—malignant glioma	5.53e-05	0.000255	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CAV1—malignant glioma	5.52e-05	0.000255	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KDR—malignant glioma	5.51e-05	0.000254	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KDR—malignant glioma	5.46e-05	0.000252	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—AKT1—malignant glioma	5.37e-05	0.000248	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CD—malignant glioma	5.34e-05	0.000246	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL8—malignant glioma	5.33e-05	0.000246	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CASP3—malignant glioma	5.32e-05	0.000246	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FN1—malignant glioma	5.32e-05	0.000246	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—F2—malignant glioma	5.32e-05	0.000246	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL2—malignant glioma	5.32e-05	0.000245	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FN1—malignant glioma	5.31e-05	0.000245	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—F2—malignant glioma	5.31e-05	0.000245	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—BAD—malignant glioma	5.26e-05	0.000243	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FN1—malignant glioma	5.25e-05	0.000243	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—F2—malignant glioma	5.25e-05	0.000243	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—BAD—malignant glioma	5.24e-05	0.000242	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	5.21e-05	0.00024	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	5.19e-05	0.00024	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—BAD—malignant glioma	5.19e-05	0.00024	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—AKT1—malignant glioma	5.15e-05	0.000238	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	5.14e-05	0.000237	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CD80—malignant glioma	5.1e-05	0.000236	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CASP3—malignant glioma	5.1e-05	0.000235	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APC—malignant glioma	5.09e-05	0.000235	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	5.09e-05	0.000235	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL2—malignant glioma	5.09e-05	0.000235	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CD80—malignant glioma	5.09e-05	0.000235	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	5.08e-05	0.000234	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APC—malignant glioma	5.08e-05	0.000234	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CD80—malignant glioma	5.04e-05	0.000233	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EGF—malignant glioma	5.04e-05	0.000232	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP9—malignant glioma	5.03e-05	0.000232	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	5.03e-05	0.000232	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APC—malignant glioma	5.03e-05	0.000232	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTT1—malignant glioma	5.02e-05	0.000232	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EGF—malignant glioma	5.02e-05	0.000232	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PTPN11—malignant glioma	5e-05	0.000231	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PTEN—malignant glioma	5e-05	0.000231	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PTPN11—malignant glioma	4.99e-05	0.00023	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EGF—malignant glioma	4.97e-05	0.000229	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PTPN11—malignant glioma	4.94e-05	0.000228	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—AKT1—malignant glioma	4.88e-05	0.000225	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP9—malignant glioma	4.82e-05	0.000222	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PTEN—malignant glioma	4.79e-05	0.000221	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—BRAF—malignant glioma	4.79e-05	0.000221	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—BRAF—malignant glioma	4.77e-05	0.00022	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—BRAF—malignant glioma	4.73e-05	0.000218	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS1—malignant glioma	4.7e-05	0.000217	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—AKT1—malignant glioma	4.67e-05	0.000216	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKT2—malignant glioma	4.66e-05	0.000215	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CB—malignant glioma	4.65e-05	0.000215	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKT2—malignant glioma	4.65e-05	0.000214	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—EGFR—malignant glioma	4.64e-05	0.000214	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—EGFR—malignant glioma	4.63e-05	0.000214	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—malignant glioma	4.61e-05	0.000213	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKT2—malignant glioma	4.6e-05	0.000212	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—EGFR—malignant glioma	4.58e-05	0.000211	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VEGFA—malignant glioma	4.52e-05	0.000209	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	4.48e-05	0.000207	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—STAT3—malignant glioma	4.47e-05	0.000207	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	4.46e-05	0.000206	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	4.44e-05	0.000205	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	4.42e-05	0.000204	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	4.42e-05	0.000204	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—KRAS—malignant glioma	4.38e-05	0.000202	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	4.38e-05	0.000202	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—BCHE—malignant glioma	4.37e-05	0.000202	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—KRAS—malignant glioma	4.37e-05	0.000202	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—KRAS—malignant glioma	4.33e-05	0.0002	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VEGFA—malignant glioma	4.33e-05	0.0002	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.32e-05	0.000199	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FGF2—malignant glioma	4.29e-05	0.000198	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—STAT3—malignant glioma	4.28e-05	0.000198	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FGF2—malignant glioma	4.27e-05	0.000197	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FGF2—malignant glioma	4.23e-05	0.000195	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MYC—malignant glioma	4.16e-05	0.000192	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EGFR—malignant glioma	4.07e-05	0.000188	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	4.03e-05	0.000186	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTEN—malignant glioma	4.02e-05	0.000186	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	4.02e-05	0.000185	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MDM2—malignant glioma	4.01e-05	0.000185	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MDM2—malignant glioma	4e-05	0.000185	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RAF1—malignant glioma	4e-05	0.000185	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RAF1—malignant glioma	3.99e-05	0.000184	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MYC—malignant glioma	3.98e-05	0.000184	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	3.98e-05	0.000184	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MDM2—malignant glioma	3.96e-05	0.000183	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ERBB2—malignant glioma	3.96e-05	0.000183	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RAF1—malignant glioma	3.95e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ERBB2—malignant glioma	3.94e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ERBB2—malignant glioma	3.9e-05	0.00018	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	3.9e-05	0.00018	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EGFR—malignant glioma	3.89e-05	0.00018	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	3.89e-05	0.00018	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	3.85e-05	0.000178	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—KRAS—malignant glioma	3.84e-05	0.000177	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL8—malignant glioma	3.75e-05	0.000173	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL8—malignant glioma	3.74e-05	0.000173	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL8—malignant glioma	3.7e-05	0.000171	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—KRAS—malignant glioma	3.68e-05	0.00017	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3.62e-05	0.000167	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	3.61e-05	0.000167	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CASP3—malignant glioma	3.59e-05	0.000166	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL2—malignant glioma	3.58e-05	0.000165	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CASP3—malignant glioma	3.58e-05	0.000165	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	3.58e-05	0.000165	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL2—malignant glioma	3.57e-05	0.000165	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CASP3—malignant glioma	3.54e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL2—malignant glioma	3.54e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	3.53e-05	0.000163	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTP1—malignant glioma	3.48e-05	0.000161	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—malignant glioma	3.41e-05	0.000158	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP9—malignant glioma	3.39e-05	0.000157	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAT—malignant glioma	3.39e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP9—malignant glioma	3.38e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	3.38e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PTEN—malignant glioma	3.37e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PTEN—malignant glioma	3.36e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP9—malignant glioma	3.35e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PTEN—malignant glioma	3.33e-05	0.000154	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—AKT1—malignant glioma	3.29e-05	0.000152	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—AKT1—malignant glioma	3.28e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—malignant glioma	3.27e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—AKT1—malignant glioma	3.25e-05	0.00015	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NCOR1—malignant glioma	3.2e-05	0.000148	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VEGFA—malignant glioma	3.05e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VEGFA—malignant glioma	3.04e-05	0.00014	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—STAT3—malignant glioma	3.02e-05	0.000139	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VEGFA—malignant glioma	3.01e-05	0.000139	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—STAT3—malignant glioma	3.01e-05	0.000139	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.98e-05	0.000137	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AKT1—malignant glioma	2.88e-05	0.000133	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CA—malignant glioma	2.84e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MYC—malignant glioma	2.8e-05	0.000129	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MYC—malignant glioma	2.79e-05	0.000129	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MYC—malignant glioma	2.77e-05	0.000128	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AKT1—malignant glioma	2.76e-05	0.000127	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.74e-05	0.000127	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EGFR—malignant glioma	2.73e-05	0.000126	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.71e-05	0.000125	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAV1—malignant glioma	2.61e-05	0.00012	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.59e-05	0.00012	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KRAS—malignant glioma	2.58e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KRAS—malignant glioma	2.56e-05	0.000118	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	2.38e-05	0.00011	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.37e-05	0.00011	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	2.37e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	2.35e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—AKT1—malignant glioma	2.32e-05	0.000107	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—malignant glioma	2.3e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—malignant glioma	2.29e-05	0.000106	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARG—malignant glioma	2.29e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—malignant glioma	2.27e-05	0.000105	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.09e-05	9.63e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.94e-05	8.97e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKT1—malignant glioma	1.94e-05	8.95e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.92e-05	8.86e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.82e-05	8.4e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—malignant glioma	1.8e-05	8.32e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTEN—malignant glioma	1.57e-05	7.26e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.11e-05	5.12e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AKT1—malignant glioma	9.06e-06	4.18e-05	CbGpPWpGaD
